Kansal Impex Private Limited
About Kansal Impex Private Limited
Data last updated:
Kansal Impex Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2009PTC191408. Its GSTIN is 09AAECK1542L1ZE (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.8 Lakh. It is led by directors Rekha Kansal and Moti Lal Kansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 614 Gobind Appartments Vasundhra Enclave, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.59 Cr, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹1.99 Lakh (net margin 1.3%) and EBITDA of ₹9.97 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 20% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kansal Impex Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address614 Gobind Appartments Vasundhra Enclave, Delhi, India – 110096
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Kansal Impex Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kansal Impex is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kansal Impex Private Limited, buy the company report.
Financials of Kansal Impex Private Limited
FY 2025 filings availableKansal Impex Private Limited reported revenue of ₹1.59 Cr (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹9.97 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kansal Impex Private Limited, buy the company report.
Board of directors of Kansal Impex Private Limited
Kansal Impex has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Kansal | Director | 19 Jun 2009 | 17 Years 4 Months | Current |
| Moti Lal Kansal Also directs: Sunrise Realtymart Private Limited | Director | 19 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Kansal Impex Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Taswin Pharma Private Limited | ₹1.59 Cr (FY 2024) | 0.0% | Jaipur, Rajasthan, India | |||
| Numanta Care Private Limited | ₹1.59 Cr (FY 2024) | -23.0% | Raipur, Chhattisgarh, India | |||
| Kansal Impex Private Limitedthis company | ₹1.59 Cr (FY 2025) | ₹1.99 Lakh | 1.3% | -29.0% | Delhi, India | |
| Avaneesh Life Sciences Private Limited | ₹1.59 Cr (FY 2024) | -1.0% | Burhanpur, Madhya Pradesh, India | |||
| Fairdeal Formulations (India) Pvt Ltd | ₹1.59 Cr (FY 2025) | 72.0% | Indore, Madhya Pradesh, India | |||
| Maruthi Biosciences Private Limited | ₹1.58 Cr (FY 2024) | 24.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Kansal Impex Private Limited, buy the company report.
Auditor
Kansal Impex Private Limited is audited by S P M S & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P M S & ASSOCIATES | FY 2021 | 015808N |
Shareholding
The shareholding of Kansal Impex Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Kansal Impex Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kansal Impex Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kansal Impex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kansal Impex has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECK1542L1ZE | Uttar Pradesh | Active | 05 Jun 2018 |
To see the full GST registrations and return filing status of Kansal Impex Private Limited, buy the company report.
Recent activity
Kansal Impex Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Moti Lal Kansal was appointed as Director on 19 Jun 2009.
Frequently asked questions
Kansal Impex is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 June 2009 (17+ years old) and is registered under CIN U51909DL2009PTC191408.
Kansal Impex has 2 current directors:
- Rekha Kansal - Director
- Moti Lal Kansal - Director
The latest financial statements of Kansal Impex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kansal Impex is 09AAECK1542L1ZE, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Kansal Impex is U51909DL2009PTC191408. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kansal Impex was incorporated on 19 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kansal Impex by revenue are Taswin Pharma Private Limited, Numanta Care Private Limited, Avaneesh Life Sciences Private Limited, Fairdeal Formulations (India) Pvt Ltd, Maruthi Biosciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Moti Lal Kansal was appointed as Director on 19 Jun 2009. Rekha Kansal was appointed as Director on 19 Jun 2009.
The registered office of Kansal Impex is at 614 Gobind Appartments Vasundhra Enclave, Delhi, India – 110096.
Kansal Impex operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Kansal Impex is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.